Skip to main content
Pavlos Msaouel, MD, Oncology, Houston, TX

Pavlos Msaouel MD PhD


Assistant Professor, Department of Genitourinary Medical Oncology

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Dr. Msaouel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineChief Residency, Internal Medicine, 2014 - 2015
  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2011 - 2014
  • University of Athens
    University of AthensClass of 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2016 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • Comparative transcriptomic profiling of renal medullary carcinoma (RMC) to determine distinct signatures and pathways associated with response to chemotherapy. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • MD Anderson Unveils January 2025 Research Breakthroughs in Cancer Science
    MD Anderson Unveils January 2025 Research Breakthroughs in Cancer ScienceJanuary 22nd, 2025
  • MD Anderson Research Highlights for January 22, 2025
    MD Anderson Research Highlights for January 22, 2025January 22nd, 2025
  • KCA Brings Early-Career Clinicians Together for New Mentorship Program
    KCA Brings Early-Career Clinicians Together for New Mentorship ProgramNovember 14th, 2024
  • Join now to see all

Grant Support

  • Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic AlleviationUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2029
  • Mechanisms of Hyperprogression to Immunotherapy in SMARCB1-Deficient Renal MalignanciesUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2029
  • Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic AlleviationUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2029

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: